Search Results Search Sort by RelevanceMost Recent AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702. Policy Forum Feb 2016 Regulations’ Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? Joel T. Adler, MD, MPH and David A. Axelrod, MD, MBA Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit. AMA J Ethics. 2016;18(2):133-142. doi: 10.1001/journalofethics.2017.18.2.pfor1-1602. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Podcast Nov 2019 Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation. Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768. Policy Forum Jun 2018 Defining Adequate Quality and Safety Metrics for Burn Care Laura S. Johnson, MD and Jeffrey W. Shupp, MD Burn care physicians must walk a fine line between providing individualized care and applying population-based quality metrics. AMA J Ethics. 2018;20(6):567-574. doi: 10.1001/journalofethics.2018.20.6.pfor1-1806. Policy Forum Oct 2004 The Universal Protocol Dennis S. O'Leary, MD Virtual Mentor. 2004;6(10):456-458. doi: 10.1001/virtualmentor.2004.6.10.pfor1-0410. Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
AMA Code Says Sep 2021 AMA Code of Medical Ethics’ Opinions Related to Implantable Devices Robert Dinallo The AMA Code of Medical Ethics offers guidance for balancing need for safety with demand for innovation. AMA J Ethics. 2021;23(9):E702-704. doi: 10.1001/amajethics.2021.702.
Policy Forum Feb 2016 Regulations’ Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered? Joel T. Adler, MD, MPH and David A. Axelrod, MD, MBA Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit. AMA J Ethics. 2016;18(2):133-142. doi: 10.1001/journalofethics.2017.18.2.pfor1-1602.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Podcast Nov 2019 Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
Medicine and Society Aug 2022 Clinicians’ Racial Biases as Pathways to Iatrogenic Harms for Black People Keisha Ray, PhD Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm. AMA J Ethics. 2022;24(8):E768-772. doi: 10.1001/amajethics.2022.768.
Policy Forum Jun 2018 Defining Adequate Quality and Safety Metrics for Burn Care Laura S. Johnson, MD and Jeffrey W. Shupp, MD Burn care physicians must walk a fine line between providing individualized care and applying population-based quality metrics. AMA J Ethics. 2018;20(6):567-574. doi: 10.1001/journalofethics.2018.20.6.pfor1-1806.
Policy Forum Oct 2004 The Universal Protocol Dennis S. O'Leary, MD Virtual Mentor. 2004;6(10):456-458. doi: 10.1001/virtualmentor.2004.6.10.pfor1-0410.
Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.